title: Androgen deprivation therapy for prostate cancer: friend or foe to the cardiovascular system?
authors.affiliation: Department of Urology, The First Affiliated Hospital of Anhui Medical University, and Institute of Urology, Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui Province, People's Republic of China.
authors.forename: Kaiping
authors.initials: K
authors.lastname: Zhang
authors.affiliation: Department of Urology, The First Affiliated Hospital of Anhui Medical University, and Institute of Urology, Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui Province, People's Republic of China.
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
authors.affiliation: Department of Urology, The First Affiliated Hospital of Anhui Medical University, and Institute of Urology, Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui Province, People's Republic of China.
authors.forename: Zongyao
authors.initials: Z
authors.lastname: Hao
authors.affiliation: Department of Urology, The First Affiliated Hospital of Anhui Medical University, and Institute of Urology, Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui Province, People's Republic of China. liang_chaozhao@163.com.
authors.forename: Chaozhao
authors.initials: C
authors.lastname: Liang
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000209:etiology*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D008297:Male; D009919:Orchiectomy / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000628:therapy*
chemical_list: D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone